Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018

키워드

참고문헌 (36)

1. Asmundson GJ, "Panic disorder and agoraphobia : an overview and commentary on DSM-5 changes", Depress Anxiety, 31, pp.480~486 (2014)
2. "Treatment of patients with panic disorder 2009"[URL]
3. Perna G, "Novel investigational therapeutics for panic disorder", Expert Opin Investig Drugs, 24, pp.491~505 (2015)
4. Bandelow B, "Pharmacological treatment of panic disorder", Mod Trends Pharmacopsychiatry, 29, pp.128~143 (2013)
5. Freire RC, "Treatment-resistant panic disorder : a systematic review", Expert Opin Pharmacother, 17, pp.159~168 (2016)
6. Perna G, "Emerging drugs for panic disorder", Expert Opin Emerg Drugs, 16, pp.631~645 (2011)
7. Freire RC, "New treatment options for panic disorder : clinical trials from 2000 to 2010", Expert Opin Pharmacother, 12, pp.1419~1428 (2011)
8. Freire RC, "Update on pharmacological treatment of panic disorder", Minerva Psichiatrica, 52, pp.145~155 (2011)
9. Boutros NN, "Anticonvulsant medications for panic disorder : A review and synthesis of the evidence", Int J Psychiatry Clin Pract, 18, pp.2~10 (2014)
10. Deppermann S, "Does rTMS Alter Neurocognitive Functioning in Patients with Panic Disorder", Agoraphobia? An fNIRS-Based Investigation of Prefrontal Activation during a Cognitive Task and Its Modulation via Sham-Controlled rTMS, 2014, pp.2014, 542526~
11. Li H, "Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults", Cochrane Database Syst Rev, (9), pp.CD009083~ (2014)
12. Bernik M, "Effect of single doses of pindolol and d-fenfluramine on flumazenil-induced anxiety in panic disorder patients", Behav Brain Res, 357-358, pp.82~87 (2019)
13. Deppermann S, "Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder", agoraphobia during cognitivebehavioural therapy, 2017, pp.16, 668~677
14. Goddard AW, "A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder", Ann Gen Psychiatry, 14, pp.26~ (2015)
15. Mantovani A, "Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression", J Affect Disord, 144, pp.153~159 (2013)
16. Kwan-Woo Choi, "Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter Trial", Clinical Psychopharmacology and Neuroscience, 10(1), pp.44~48 (2012), 대한정신약물학회[DOI]
17. Shah A, "An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder", Ann Gen Psychiatry, 17, pp.19~ (2018)
18. Buoli M, "Slow vs standard up-titration of paroxetine in the treatment of panic disorder : a prospective randomized trial", Psychiatry Clin Neurosci, 64, pp.612~619 (2010)
19. Marquez M, "Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders", Actas Esp Psiquiatr, 39, pp.88~94 (2011)
20. Nardi A, "Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder", Psychiatry Res, 175, pp.260~265 (2010)
21. Nardi A, "Psychopharmacotherapy of panic disorder : 8-week randomized trial with clonazepam and paroxetine", Braz J Med Biol Res, 44, pp.366~373 (2011)
22. Nardi A, "A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine", J Clin Psychopharmacol, 32, pp.120~126 (2012)
23. Goddard A, "A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder", Ann Gen Psychiatry, 14, pp.26~ (2015)
24. Prasko J, "The effect of repetitive transcranial magnetic stimulation(rTMS)add on serotonin reuptake inhibitors in patients with panic disorder : a randomized, double blind sham controlled study", Neuro Endocrinol Lett, 28, pp.33~38 (2007)
25. Freire RC, "Current pharmacological interventions in panic disorder", CNS Neurol Disord Drug Targets, 13, pp.1057~1065 (2014)
26. Freire RC, "A 6-year posttreatment follow-up of panic disorder patients : treatment with clonazepam predicts lower recurrence than treatment with paroxetine", J Clin Psychopharmacol, 37, pp.429~434 (2017)
27. piperazine(Lu AA21004) : a novel multimodal compound for the treatment of major depressive disorder, "J Med Chem", 2011, 3206~3221
28. Sanchez C, "Vortioxetine, a novel antidepressant with multimodal activity : review of preclinical and clinical data", Pharmacol Ther, 145, pp.43~57 (2015)
29. Connolly KR, "Vortioxetine : a new treatment for major depressive disorder", Expert Opin Pharmacother, 17, pp.421~431 (2016)
30. Guaiana G, "Antidepressants and benzodiazepines for panic disorder in adults", Cochrane Database Syst Rev, 9, pp.CD011567~ (2016)
31. Moylan S, "The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder", J Clin Psychopharmacol, 31, pp.647~652 (2011)
32. Merideth C, "Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder : a randomized, placebo controlled and active-controlled study", Int Clin Psychopharmacol, 27, pp.40~54 (2012)
33. Bandelow B, "Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study", Int J Neuropsychopharmacol, 13, pp.305~320 (2010)
34. Prosser JM, "A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks : a randomized, single-blind study", BMC Psychiatry, 9, pp.25~ (2009)
35. Sepede G, "Olanzapine augmentation in treatment-resistant panic disorder : a 12-week, fixed-dose, open-label trial", J Clin Psychopharmacol, 26, pp.45~49 (2006)
36. Hoge EA, "Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder", CNS Spectr, 13, pp.522~527 (2008)

관련 논문AI추천